Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Hnpmi | 1980848-48-3 | 99.6% | 360.41 | 50 MG
SDP

Catalog No. 5000392820
Encompass_Preferred

HNPMI is an EGFR inhibitor that exhibits cytotoxic effects on tumor cells. It downregulates protein levels of osteopontin, survivin, and cathepsin S, inducing apoptosis. Additionally, HNPMI modulates BCL-2/BAX and p53 in CRC cell lines to hinder tumorigenesis.

  • Inhibitor of EGFR.
  • Cytotoxic effects on tumor cells.
  • Downregulates osteopontin, survivin, and cathepsin S.
  • Induces apoptosis.
  • Regulates BCL-2/BAX and p53 in CRC cell lines.

Catalog No. 50-003-92820 Supplier Medchemexpress LLC Supplier No. HY16214850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

HNPMI is an EGFR inhibitor that exhibits cytotoxic effects on tumor cells. It downregulates protein levels of osteopontin, survivin, and cathepsin S, inducing apoptosis. Additionally, HNPMI modulates BCL-2/BAX and p53 in CRC cell lines to hinder tumorigenesis.

  • Inhibitor of EGFR.
  • Cytotoxic effects on tumor cells.
  • Downregulates osteopontin, survivin, and cathepsin S.
  • Induces apoptosis.
  • Regulates BCL-2/BAX and p53 in CRC cell lines.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.